HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lulu An Selected Research

Lulu An Research Topics

Disease

3Inflammation (Inflammations)
11/2021 - 01/2020
3Fibrosis (Cirrhosis)
11/2021 - 01/2021
2Lung Diseases (Lung Disease)
12/2021 - 01/2020
1Chronic Obstructive Pulmonary Disease (COPD)
12/2021
1Dysbiosis
11/2021
1Cardiotoxicity
11/2021
1Ulcer
11/2021
1Memory Disorders (Memory Loss)
06/2021
1Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy)
06/2021
1Cerebral Hemorrhage
01/2021
1Cardiomegaly (Heart Hypertrophy)
01/2021
1Cognitive Dysfunction
01/2021
1Body Weight (Weight, Body)
01/2021
1Hypochromic Anemia (Chlorosis)
04/2020
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1Infections
01/2020
1Airway Obstruction (Choking)
01/2020

Drug/Important Bio-Agent (IBA)

2Therapeutic UsesIBA
12/2021 - 01/2020
2salicylhydroxamic acid (SHAM)IBA
06/2021 - 01/2021
2NADP (NADPH)IBA
01/2021 - 01/2021
1S-allylmercapto-N-acetylcysteineIBA
12/2021
1Pharmaceutical PreparationsIBA
12/2021
1monodansylcadaverineIBA
12/2021
1Pancreatic Elastase (Elastase)IBA
12/2021
116S Ribosomal RNAIBA
11/2021
1EndotoxinsIBA
11/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021
1Zonula Occludens-1 ProteinIBA
11/2021
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2021
1Amyloid beta-PeptidesIBA
06/2021
1Aquaporin 4IBA
06/2021
1Interleukin-1 Receptor-Associated KinasesIBA
06/2021
1MetalloproteinsIBA
01/2021
1Metoprolol (Toprol-XL)FDA LinkGeneric
01/2021
14-hydroxy-2-nonenal (4-hydroxynonenal)IBA
01/2021
1ThrombinFDA Link
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2021
1Interleukin-6 (Interleukin 6)IBA
01/2021
1Transforming Growth Factor beta (TGF-beta)IBA
01/2021
1NF-kappa B (NF-kB)IBA
01/2021
1Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
01/2021
1IonsIBA
04/2020
1CalcineurinIBA
04/2020
1Protein Kinases (Protein Kinase)IBA
04/2020
1Sulfur Compounds (Compounds, Sulfur)IBA
01/2020
1MucinsIBA
01/2020
1S-allylmercaptocysteineIBA
01/2020